D
Context Therapeutics Inc. CNTX
$0.8595 -$0.0134-1.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -291.55% -24.80% 50.62% -197.20% 55.01%
Total Depreciation and Amortization 57.69% 57.69% 11.54% -9.68% -18.75%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 164.84% 33.21% 0.39% 5,606.48% -48.61%
Change in Net Operating Assets 304.01% 17.16% -154.77% -74.67% -1,863.50%
Cash from Operations -73.88% -15.31% 32.11% 44.14% 27.54%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -100.00% -- -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -106.38% -16.44% 233.22% -383.55% 2,074.64%